Poland – Laboratory reagents – Successive delivery of specialized reagents for cfDNA analysis as part of the N-BRAVE clinical trial (PLRG-HL05)
TenderZenith matches this tender's eligibility criteria against your company profile to calculate a deterministic qualification score and identify potential disqualifiers.
A structured breakdown of scope, eligibility requirements, submission steps, and key conditions — extracted directly from the official notice.
Sign in to unlock Bid Fit & AI Opportunity Intelligence
TenderZenith calculates a personalized qualification score against your company profile and extracts structured intelligence from tender documents with your 7-Day Pro Trial (No Credit Card Required).
Description & Project Overview
Changes and clarification of the content of the SWZ and other procurement documents directly related to the procurement procedure will be made available on the website: https://platformazakupowa.pl/transakcja/1397981 1. The subject of the order is the successive delivery of specialized reagents for cfDNA analysis as part of the N-BRAVE clinical trial (PLRG-HL05) entitled: "Evaluation of the effectiveness and tolerability of the N-AVD regimen compared to the BrE-CADD regimen in patients with advanced Hodgkin lymphoma" implemented by the Medical University of Gdańsk under the co-financing agreement no.
Related Procurement Opportunities
Similar tenders in Chemicals, laboratory equipment and services